Kindred Biosciences, Inc. (KIN) earnings
Quarterly and annual KIN reports and results, each read against the price at its own news timestamp. Back to the KIN overview →
No KIN earnings events in the measured window.
Nothing matched in the current window — the KIN overview has every event we measure for this name.
Get an email when KIN moves on news →Keep exploring
More KIN: analyst actions → · SEC filings → · KIN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Opiant Pharmaceuticals, Inc. (OPNT) | 654 | 0.00% | 41% |
| ADURO BIOTECH (ADRO) | 650 | -0.16% | 42% |
| Otonomy, Inc. (OTIC) | 649 | 0.00% | 48% |
| Sierra Oncology, Inc. (SRRA) | 649 | -0.03% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.